Samuel Rubinstein

6PUBLICATIONS
61CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 02, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study.

Samia Shabnaz, Eric Farber-Eger, Marwa Tantawy

|Jan 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare Analysis.

Matthew R LeBlanc, Xi Zhou, Christopher D Baggett

|Oct 17, 2024
Novel use of Siltuximab in a patient with VEXAS Syndrome.

Beatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha

|Sep 06, 2024
Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease.

Divaya Bhutani, Yusha Liu, Rajshekhar Chakraborty

|May 24, 2024
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma.

Samia Shabnaz, Trang N Nguyen, Roy Williams

|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

Pageof 1

Frequent Collaborators

2 joint publications

Mohammed E Alomar

2 joint publications

Robert F Cornell

2 joint publications

Kenneth H Shain

2 joint publications

Yan Gong